Physician profile
Keith D Cook
NPI 1235243106
$78,021.38
in general payments reported to CMS, 2019-2025
25 companies · $4,183 in 2025
The $4,183 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $8,369 · 2021: $18K · 2022: $23K · 2023: $6,932 · 2024: $5,108 · 2025: $4,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Food and Beverage: $2,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,573.83 |
| Food and Beverage | $2,647.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $32,920.20 | 2020-2022 | |
| Osteomed LLC | $25,152.70 | 2019-2022 | |
| Acumed LLC | $13,573.83 | 2023-2025 | Osteomed |
| Ossio INC | $1,324.89 | 2021-2023 | |
| Stryker Corporation | $1,281.97 | 2021-2025 | Citrefix, Actishield, 7 X 23mm Citrelock Implant |
| Musculoskeletal Transplant Foundation INC. | $1,036.78 | 2019-2025 | |
| Kerecis Limited | $981.85 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $475.63 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $410.18 | 2019-2022 | |
| Orthofix Medical, INC. | $158.86 | 2023 | Truelok, Trinity Elite, Truelok System |
| Medshape, INC. | $117.95 | 2023 | Dynanail Helix, Washer, 15 Mm, Dynanail Hybrid |
| Smith+Nephew, INC. | $113.49 | 2019-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Misonix INC | $105.70 | 2021 | |
| Depuy Synthes Sales INC. | $98.93 | 2022 | |
| Polynovo North America LLC | $67.22 | 2022-2024 | Novosorb Btm |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $41.92 | 2023 | Restrata Wound Matrix |
| Paragon 28, INC. | $24.51 | 2021 | |
| Mimedx Group, INC. | $23.75 | 2025 | |
| Next Science LLC | $22.64 | 2023 | Xperience, Blastx, Surgx |
| Dynasplint Systems INC. | $21.78 | 2019 | |
| Abbvie INC. | $16.88 | 2021 | |
| Averitas Pharma INC. | $13.84 | 2025 | Qutenza |
| Royal Biologics, INC. | $12.59 | 2021 | |
| Bone Support INC. | $12.33 | 2022 | |
| Wright Medical Technology, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.